Phio Pharmaceuticals Corp... (PHIO)
NASDAQ: PHIO
· Real-Time Price · USD
2.05
0.05 (2.50%)
At close: Jun 02, 2025, 3:59 PM
2.00
-2.40%
After-hours: Jun 02, 2025, 07:52 PM EDT
2.50% (1D)
Bid | 2 |
Market Cap | 9.84M |
Revenue (ttm) | n/a |
Net Income (ttm) | -6.76M |
EPS (ttm) | -9.02 |
PE Ratio (ttm) | -0.23 |
Forward PE | n/a |
Analyst | Buy |
Ask | 2.07 |
Volume | 135,069 |
Avg. Volume (20D) | 3,108,969 |
Open | 1.97 |
Previous Close | 2.00 |
Day's Range | 1.97 - 2.06 |
52-Week Range | 0.97 - 9.79 |
Beta | 0.84 |
About PHIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PHIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PHIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+18.6%
Phio Pharmaceuticals shares are trading higher aft...
Unlock content with
Pro Subscription
1 month ago
+52.48%
Phio Pharmaceuticals shares are trading higher after the company announced its Safety Monitoring Committee recommended dose escalation in the Phase 1b trial of PH-762.